Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:54 pm Sale |
2024-12-31 | 13G | IO Biotech, Inc. IOBT |
Samsara BioCapital, L.P. | 2,631,578 3.800% |
-1,008,437 (-27.70%) |
Filing History |
| 2025-02-13 4:15 pm Purchase |
2023-12-31 | 13G | IO Biotech, Inc. IOBT |
HBM BIOVENTURES CAYMAN LTD | 5,523,439 8.200% |
1,578,947 (+40.03%) |
Filing History |
| 2024-11-13 5:30 pm Sale |
2024-09-30 | 13G | IO Biotech, Inc. IOBT |
Stonepine Capital Management, LLC | 0 0.000% |
-3,641,345 (Position Closed) |
Filing History |
| 2024-09-17 9:01 pm Sale |
2024-09-13 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 5,823,584 8.500% |
-1,075,000 (-15.58%) |
Filing History |
| 2024-05-14 9:35 pm Sale |
2024-05-10 | 13G | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 6,898,584 10.100% |
-658,809 (-8.72%) |
Filing History |
| 2024-02-14 09:00 am Sale |
2023-12-31 | 13G | IO Biotech, Inc. IOBT |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-2,055,883 (Position Closed) |
Filing History |
| 2024-02-13 9:34 pm Sale |
2024-02-09 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 7,557,393 11.100% |
-658,809 (-8.02%) |
Filing History |
| 2024-02-13 7:38 pm Sale |
2023-12-31 | 13G | IO Biotech, Inc. IOBT |
BANK OF AMERICA CORP BAC |
1,844,185 2.800% |
-10,000 (-0.54%) |
Filing History |
| 2024-02-13 4:29 pm Sale |
2023-12-31 | 13G | IO Biotech, Inc. IOBT |
Stonepine Capital Management, LLC | 3,641,345 5.400% |
-309,271 (-7.83%) |
Filing History |
| 2024-02-13 4:06 pm Sale |
2023-12-31 | 13G | IO Biotech, Inc. IOBT |
HBM BIOVENTURES CAYMAN LTD | 3,944,492 6.000% |
-1,578,947 (-28.59%) |
Filing History |
| 2023-12-18 5:14 pm Purchase |
2023-08-09 | 13G | IO Biotech, Inc. IOBT |
Samsara BioCapital, L.P. | 3,640,015 5.500% |
3,640,015 (New Position) |
Filing History |
| 2023-09-07 10:36 am Purchase |
2023-08-31 | 13G | IO Biotech, Inc. IOBT |
Kurma Partners | 12,253,230 17.180% |
12,253,230 (New Position) |
Filing History |
| 2023-08-16 4:15 pm Purchase |
2023-08-07 | 13G | IO Biotech, Inc. IOBT |
Stonepine Capital Management, LLC | 3,950,616 5.800% |
3,950,616 (New Position) |
Filing History |
| 2023-08-15 3:15 pm Purchase |
2023-08-09 | 13G | IO Biotech, Inc. IOBT |
HBM BIOVENTURES CAYMAN LTD | 5,523,439 8.190% |
1,524,008 (+38.11%) |
Filing History |
| 2023-08-14 3:45 pm Purchase |
2023-08-09 | 13G | IO Biotech, Inc. IOBT |
HBM BIOVENTURES CAYMAN LTD | 3,999,431 6.100% |
1,578,947 (+65.23%) |
Filing History |
| 2023-08-14 3:45 pm Purchase |
2023-08-09 | 13D | IO Biotech, Inc. IOBT |
Lundbeckfond Invest A/S | 21,851,920 29.600% |
15,802,468 (+261.22%) |
Filing History |
| 2023-08-11 4:40 pm Purchase |
2023-08-09 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 8,216,202 12.000% |
4,938,270 (+150.65%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | IO Biotech, Inc. IOBT |
RA Capital Management, L.P. | 1,127,260 3.900% |
-730,495 (-39.32%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | IO Biotech, Inc. IOBT |
PFM Health Sciences, LP | 507,640 1.800% |
-1,002,496 (-66.38%) |
Filing History |
| 2023-02-14 08:11 am Purchase |
2022-12-31 | 13G | IO Biotech, Inc. IOBT |
BANK OF AMERICA CORP BAC |
1,854,185 6.400% |
1,854,185 (New Position) |
Filing History |